Associated Papers
Interleukin-36 receptor antagonist deficiency patient with a novel mutation.
Sezer M et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie, 2026
Amoxicillin-Triggered Flare of Generalized Pustular Psoriasis in a Patient With Homozygous IL36RN Pathogenic Variant Treated With Spesolimab and Cyclosporin A.
Morita K et al.
The Journal of Dermatology, 2026
Whole-genome sequencing reveals rare and structural variants contributing to psoriasis and identifies CERCAM as a risk gene.
Sonehara K et al.
Cell Genomics, 2025
Epidemiological, Genetic, Clinical, and Treatment Differences of Generalized Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Across Ethnicities: A Systematic Review.
Hsu FL et al.
American Journal of Clinical Dermatology, 2025
Generalized pustular psoriasis: immunological mechanisms, genetics, and emerging therapeutics.
Lee CC et al.
Trends in Immunology, 2025
IL-36RN gene: key insights into its role in pediatric pustular psoriasis pathogenesis and treatment.
Wang Y et al.
Frontiers in Pediatrics, 2025
Generalized acrodermatitis continua of Hallopeau with an IL36RN variant successfully treated with bimekizumab.
Yoshikawa T et al.
The Journal of Dermatology, 2024
IL36RN mutations in Chinese patients with acute generalized exanthematous pustulosis.
Li Z et al.
International Journal of Dermatology, 2024
Targeted review of IL36RN mutations in patients with generalised pustular psoriasis.
Krueger JG et al.
Skin Health and Disease, 2024
Cutaneous findings and treatments in deficiency of interleukin-36 receptor antagonist (DITRA): A review of the literature.
Okorie CL et al.
Experimental Dermatology, 2024
Acute generalized exanthematous pustulosis caused by hydroxychloroquine in a patient with rheumatoid arthritis and CARD14 mutation: Case report.
Luo F et al.
Medicine, 2023
A viewpoint on the genetic determinants of generalised pustular psoriasis.
Capon F
Experimental Dermatology, 2023
Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review.
Prinz JC et al.
Journal of the European Academy of Dermatology and Venereology : Jeadv, 2023
Neutrophil extracellular traps are involved in enhanced contact hypersensitivity response in IL-36 receptor antagonist-deficient mice.
Hasegawa Y et al.
Scientific Reports, 2022
Pustular psoriasis of pregnancy: Clinical and genetic characteristics in a series of eight patients and review of the literature.
Ennouri M et al.
Dermatologic Therapy, 2022
Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond.
Sugiura K
Dermatology and Therapy, 2022
Generalized pustular psoriasis with deficiency of interleukin-36 receptor antagonist associated with sensorineural hearing impairment.
Ichiyama S et al.
The Journal of Dermatology, 2021
Successful treatment of a 3-year-old girl with generalized pustular psoriasis using secukinumab monotherapy.
Zhu H et al.
Pediatric Dermatology, 2021
An update on genetic basis of generalized pustular psoriasis (Review).
Zhou J et al.
International Journal of Molecular Medicine, 2021
Significance of IL36RN mutation analyses in the management of impetigo herpetiformis: A case report and review of published cases.
Yoshikawa M et al.
The Journal of Dermatology, 2021
Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: A PRISMA-compliant systematic review and meta-analysis.
Liu ZJ et al.
Medicine, 2020
The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals.
Cao Y et al.
Cell Research, 2020
TAK-242 ameliorates contact dermatitis exacerbated by IL-36 receptor antagonist deficiency.
Fukushima H et al.
Scientific Reports, 2020
The GenomeAsia 100K Project enables genetic discoveries across Asia.
Unknown Author
Nature, 2019
Generalized pustular psoriasis from heterozygous IL36RN mutation developed after liver surgery.
Fukushima H et al.
The Journal of Dermatology, 2019
A case of generalized pustular psoriasis caused by hydroxychloroquine in a patient with systemic lupus erythematosus.
Shindo E et al.
Lupus, 2019
Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP.
Fujita H et al.
The Journal of Dermatology, 2018
Codeine-induced acute generalized exanthematous pustulosis without IL36RN mutations.
Chadli Z et al.
Pharmacogenomics, 2018
Generalized pustular psoriasis in a 92-year-old man with a homozygous nonsense mutation in IL36RN.
Ueda Y et al.
The Journal of Dermatology, 2018
Clinical profiles of pediatric patients with GPP alone and with different IL36RN genotypes.
Wang Y et al.
Journal of Dermatological Science, 2017
Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations.
Martorana D et al.
Frontiers in Immunology, 2017
IL36RN Mutations Affect Protein Expression and Function: A Basis for Genotype-Phenotype Correlation in Pustular Diseases.
Tauber M et al.
The Journal of Investigative Dermatology, 2016
Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients.
Wang TS et al.
Archives of Dermatological Research, 2016
IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis.
Hussain S et al.
The Journal of Allergy and Clinical Immunology, 2015
Acute generalized exanthematous pustulosis caused by dihydrocodeine phosphate in a patient with psoriasis vulgaris and a heterozygous IL36RN mutation.
Nakai N et al.
Jama Dermatology, 2015
IL36RN gene analysis of two Japanese patients with generalized pustular psoriasis.
Shiratori T et al.
International Journal of Dermatology, 2015
Novel IL36RN gene mutation revealed by analysis of 8 Japanese patients with generalized pustular psoriasis.
Hayashi M et al.
Journal of Dermatological Science, 2014
Varicella zoster virus-associated generalized pustular psoriasis in a baby with heterozygous IL36RN mutation.
Sugiura K et al.
Journal of the American Academy of Dermatology, 2014
IL36RN mutations underlie impetigo herpetiformis.
Sugiura K et al.
The Journal of Investigative Dermatology, 2014
IL36RN mutation causing generalized pustular psoriasis in a Palestinian patient.
Renert-Yuval Y et al.
International Journal of Dermatology, 2014
The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
Sugiura K
Journal of Dermatological Science, 2014
Generalized pustular psoriasis triggered by amoxicillin in monozygotic twins with compound heterozygous IL36RN mutations: comment on the article by Navarini et al.
Sugiura K et al.
The Journal of Investigative Dermatology, 2014
The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist.
Sugiura K et al.
The Journal of Investigative Dermatology, 2013
Prevalent and rare mutations in IL-36RN gene in Chinese patients with generalized pustular psoriasis and psoriasis vulgaris.
Li M et al.
The Journal of Investigative Dermatology, 2013
The expanding spectrum of rare monogenic autoinflammatory diseases.
Touitou I et al.
Orphanet Journal of Rare Diseases, 2013
Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis.
Kanazawa N et al.
The Journal of Dermatology, 2013
Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis.
Farooq M et al.
Human Mutation, 2013